书籍改编电影条款概述

以下为将《星港来信》（书信体小说，简体中文图书在售）改编为电影之关键条款要点梳理。本要点旨在作为法律谈判与合同起草的框架参考，适用中国法背景，并兼顾可按地域分授权与分账的商业安排。

一、当事人及权属核验

• 权利方：著作权人（作者/共同作者）及在先受让人（如出版社、经纪公司等）。应提供完整的权属链证明与无争议声明；确认出版合同中对“改编权/摄制权/电影权”的归属与限制。
• 受让方：制片公司/主出品方；如涉及合拍或联营，明确主控方。
• 核验重点：书信体素材是否涉及真实人物、真实信件或第三方著作，确保不存在隐私权、名誉权、肖像权、著作权等第三方权利障碍；如存在，须由权利方负责取得授权或进行有效去标识化处理。

二、权利授予范围（独占）

• 标的权利：独占且可再许可的摄制权、改编权、翻译权、汇编权，以及为电影改编所必需的一切衍生利用权（包括宣传引用、台词/人物/设定等改编再创作使用）。
• 媒介与平台：影院发行、电视播出、信息网络传播（含流媒体/点播）、航空/交通载体、校园/非商业放映等全球全媒介使用。
• 语言与版本：中文（含普通话及方言）及外语版本、字幕/配音、导演剪辑版/加长版、IMAX/4D等技术格式。
• 标题与元素：作品中文名称及外文译名的使用与变更授权；角色名、场景设定、核心情节元素之改编使用。
• 道德权利处理：在不歪曲、篡改原著核心精神的前提下，作者不可撤销地同意合理改编、删节、合并、情节重构与必要的合规性修改；保证不以“保护作品完整权”为由主张妨碍发行的权利救济（不放弃人格权但作事前同意）。
• 明示保留：除非另行约定，舞台剧、广播剧、有声书、出版再版、文学合集等可明确列为保留或由双方另行谈判。

三、地域分授权与分账机制

• 区域划分：明确“大中华区”（须清晰约定是否含中国台湾、香港、澳门）、北美、欧洲、日韩、东南亚、拉美、中东/北非等；或以“全球除外某区域”方式定义。
• 分许可权：受让方可按区域向发行商/平台再许可，但须：
  1. 书面分许可协议并向权利方备案；
  2. 约定各区域最低保证金（MG）及数据报备义务；
  3. 不得跨区域交叉抵扣成本（禁止跨区交叉塌缩）；
  4. 费用扣除范围与上限明确、经审计，宣发费用口径一致；
  5. 采用独立收款账户或引入收款账户管理（CAM），透明结算。
• 分账规则：明确毛/净的定义、可扣除成本清单、发行费率上限、回款周期（如季度）、滞纳金与审计权；权利方对各区域收入享有审计与查账权（含下游分许可对象）。

四、选购/收购结构（如采用“选购—行权—购买”）

• 选购期：独家选购期及一次续展权；续展条件与续展费。
• 选购金与购置价：选购金支付、是否可抵扣购置价；行权触发（签署主投资/发行协议、开机、资金落实等）与行权期限。
• 失败与回转：选购期满未行权或开机期限（如自行权起18–24个月）未达成，权利自动回转；受让方对已完成开发成果的使用限制与保密义务。

五、对价与收益分配

• 固定对价：权利转让/许可费之结构（预付款、分期）；是否与制作预算或票房/发行表现挂钩。
• 或有对价：票房阶梯奖金、净收益分成、平台保底超额分成、衍生权分成（如角色授权、再开发）。
• 分账明细：对“净收益”的严格定义、费用抵扣顺位与上限、不得重复计提；跨境收款的税费、预提税、外汇结汇路径（遵守SAFE相关规定）。
• 审计与报表：定期报表、留存凭证年限、每年一次或两次审计权、差错更正与审计费用分担。

六、成片权属与著作权归属

• 电影作品的著作权归属受让方（或项目SPV），权利方对成片不享有著作权，仅享约定对价与署名权利。
• 背景素材授权：权利方授予的原著素材与人物设定授权为非独家永久性用于电影及其宣发之必要引用。
• 二次开发：续集、前传、外传、衍生剧集、迷你剧、动画版、重拍、翻拍、翻拍权回收机制与权利金比例；权利方优先谈判权/最后拒绝权的设置（可选）。

七、内容合规与审查

• 中国内地拍摄/发行时的行政合规：立项备案、剧本（梗概）备案、摄制许可证、成片公映许可证等；须满足国家电影局及相关部门的审查要求。
• 修改权：为通过审查/平台上线/电视播出所需之合理修改权归受让方；作者已事先同意不以人格权对抗必要修改。
• 未通过审查的风险分配：因原著事实性内容缺陷引发的不通过/侵权责任由权利方承担；因制作方创作新增内容引发的风险由受让方承担，双方按过错或约定比例承担连带或补偿责任。

八、作者参与与署名

• 参与方式：顾问/咨询权、剧本草案征询意见的次数与时限；但创作最终决定权归受让方。
• 署名规则：片头/片尾“根据××改编”之措辞、字体、位置、字幕语言及各版本统一；宣传物料与平台页的署名义务。
• 奖项署名：参与报名行业奖项时的署名顺序与权利。

九、真实人物、隐私与书信体特殊风险控制

• 若原著中引用或基于真实信件、真实人物或可识别信息，需明确：
  1. 权利方已完成必要授权或提供可执业律师出具的法律意见；
  2. 未授权部分须在改编中进行去标识化或虚构化处理；
  3. 如有肖像/名誉/隐私争议，由提供方承担相应法律责任并为受让方提供抗辩与赔偿支持。
• E&O（差错与遗漏）保险：由受让方投保，权利方配合提供权属与授权证明。

十、交付与资料

• 权利方交付：完整文本、勘误表、已授权第三方清单及授权文书；如为连载或再版，提供最终定本版本。
• 受让方交付：在权利回转或合同终止时返还或删除权利方提供的未公开资料（保密条款继续有效）。

十一、期限与区域

• 权利许可期限：通常与电影及衍生作品保护期一致的全球期限；如采用分区域授权，明确各区域有效期与续展条件。
• 地域：全球/分区域；与分授权条款保持一致。

十二、保证、陈述与承诺

• 权利方保证：对标的作品享有可处分之完整权利；不存在一权多授/权利负担；不存在抄袭、侵害第三方法益的内容；如为多人著作或改编作品，已获得必要同意。
• 受让方保证：合法合规制作、发行、宣传；不以违法方式使用原著元素；遵守平台与监管要求。
• 违约与救济：补救期、违约金、损害赔偿、特定履行与禁令救济的适用。

十三、税务与外汇

• 境内主体收款适用中国税法并依法开具发票；跨境支付遵守外汇管理规定、结售汇要求及预提税处理；各方自行承担各自税负，另行约定代扣代缴义务。

十四、保密与公告

• 对合同条款、商业计划、分许可条件、分账数据负有保密义务；对外公告需经对方书面同意（法律强制披露除外）。

十五、争议解决与适用法律

• 适用法律：中华人民共和国法律。
• 争议解决：建议约定仲裁（如北仲/贸仲/上仲或HKIAC）以适配跨境分账与分许可；紧急救济可在有管辖权法院申请禁令。
• 管辖条款与送达：明确送达地址与电子送达有效性。

十六、不可抗力与政策变更

• 对政策/审查标准重大变化、公共卫生事件、重大技术平台规则变动之风险分担与工期顺延机制。

十七、其他

• 转让与控制权变更：受让方可在项目融资/保理/并购背景下转让或设定担保，但不得损害权利方既得收益与署名权。
• 完整协议、可分割条款、通知方式、版本语言（中文为准）、副本与电子签署效力。

法律依据（框架性提示）

• 中华人民共和国著作权法（现行）：涉及改编权、摄制权、翻译权、署名权、保护作品完整权等。
• 中华人民共和国电影产业促进法、电影管理相关规定：涉及备案、审查、公映许可等。
• 民法典人格权编与侵权责任编：涉及名誉权、肖像权、隐私权等保护。
• 相关税收与外汇管理规定：跨境收款、预提税与结售汇合规。

实务建议

• 在签署前完成尽调与权属链审计（含出版社合同与任何在先影/视/剧权授权）。
• 就分区域授权引入独立收款账户及第三方收款账户管理人（CAM），并设审计与透明报表机制，避免跨区成本交叉抵扣。
• 对书信体素材进行专项法务审核与敏感内容评估，必要时获取第三方法律意见与权利授权函。

以上条款要点可直接转化为“选购—购买—许可”结构的主协议与附件（区域分授权模板、分账标准条款、署名规范、权属证明清单），以满足《星港来信》改编电影项目的法律合规与商业可执行性要求。

Principal Terms for Option and Literary Purchase Agreement—Adaptation of “Summer Echoes” (a youth romance novel)

1. Parties and Property

• Owner/Author: [Author’s full legal name] (Author), the sole and exclusive owner of all right, title, and interest in and to the literary work currently titled “Summer Echoes” (the Property).
• Producer/Buyer: [Production company], including its financiers, successors, licensees, and assigns (Producer).
• Scope: Feature-length motion picture (live-action), including standard ancillary and allied rights customarily associated with production, distribution, and exploitation of a motion picture based on a literary work.

2. Rights Granted

• Grant: Exclusive option to acquire all motion picture rights and allied rights necessary to produce, distribute, advertise, and exploit one theatrically released feature film based on the Property, including: a) Right to adapt, translate, dramatize, arrange, and otherwise transform the Property into screenplays and production materials for one feature film, subject to the Author’s approval rights set forth herein. b) Rights to exploit the Picture in all media now known or hereafter devised, in all languages, worldwide (the Territory). c) Standard ancillary rights tied to the Picture (e.g., trailers, publicity, awards clips), soundtrack and music publishing rights with respect to new compositions created for the Picture, and limited merchandising strictly of film characters and elements created for the Picture (use of original book cover art excluded unless separately licensed).
• Reserved Rights to Author: All print publishing rights in the Property (including print/e-book and audiobook), radio and stage rights, and literary sequel and prequel publishing rights; any interactive or episodic audiovisual exploitation not expressly granted remains subject to separate negotiation unless expressly included. Author’s moral rights are reserved to the extent non-waivable under applicable law.

3. Option; Term; Extensions

• Option Fee: [Currency and amount], recoupable (but non-refundable) against the Purchase Price.
• Initial Option Period: [12–18] months from full execution and payment of the Option Fee.
• Extension: Producer may extend the Option Period once (or twice) for [6–12] months upon payment of an additional fee of [amount] per extension, recoupable against the Purchase Price.
• Exercise: Option exercisable by written notice and timely payment of the Purchase Price.

4. Purchase Price; Contingent Compensation

• Purchase Price: [Fixed amount], payable upon option exercise and delivery of chain-of-title documents. The transfer of rights will be memorialized in a separate assignment consistent with the writing requirement for copyright transfers (e.g., 17 U.S.C. § 204(a) for U.S. exploitation).
• Bonuses: Box office/streaming performance bonuses customary in the territory, e.g., upon domestic gross/qualifying subscriber benchmarks: [tiers/amounts].
• Backend: [X%] of defined net profits or [fixed corridor] of adjusted gross receipts, with a producer-standard definition and audit rights. Net definition to be attached as an exhibit.

5. Credit (Prominent Author Credit—Material Term)

• On-Screen Credit: Single-card main titles credit reading: “Based on the novel ‘Summer Echoes’ by [Author’s name]” appearing: a) In the main titles, in a size and duration no less prominent than the writer of the screenplay, and in any case not less than 100% of the font size of the screenplay-by credit; and b) In paid advertising (where any writer or source material credit appears), in the billing block or equivalent, in size no less than the director’s billing-block credit or proportional to standard source material credit, whichever is more favorable.
• Placement: If main titles are omitted, credit shall appear in the first card of the end titles ahead of the general crew roll.
• Substantial Compliance: Inadvertent, isolated lapses in advertising shall not constitute breach if promptly cured prospectively; on-screen credit is a material obligation.
• Novel Tie-In: If Producer authorizes a film-tie-in edition, Author receives customary placement as sole author with film branding standards agreed; any use of stills, key art, or film title on the tie-in edition subject to Producer’s approval.

6. Author Approval Rights (Material Term)

• Definitions: a) Material Script Change: Any material deviation from the core plot, central themes, or character arcs; changes to the ending; removal or merger of principal characters; relocation that substantially alters cultural or temporal setting; or changes that materially alter tone/genre (e.g., shifting from youth romance to another genre). b) Casting Choices: The initial hiring and any replacement of principal cast (the lead protagonists and principal antagonist(s)); cameos and day players excluded.
• Approval Requirement: Producer shall not finalize any Material Script Change nor any Casting Choice without Author’s prior written approval.
• Standard of Conduct: Approval shall not be unreasonably withheld, conditioned, or delayed. Author shall respond in writing within [10] business days after receipt of a complete submission (script draft marked to show changes; casting offer letter with role, quotes, and resume). Failure to respond within the period constitutes deemed approval.
• Iterations: Approval pertains to the locked shooting script and subsequent material revisions; non-material revisions do not require approval.
• Remedies: Breach of this clause constitutes a material breach. Prior to principal photography, Author may seek injunctive relief or specific performance to enforce approval. After lock, remedies are limited to monetary damages and corrective credit/promotional measures, to avoid enjoining distribution.

7. Consultation Rights

• Author shall have meaningful consultation rights with respect to selection of director, cinematographer, composer, and marketing positioning, with good-faith consideration by Producer. Consultation is non-binding and subject to scheduling and confidentiality.

8. Creative Materials; Access

• Producer to provide Author with: outlines and screenplay drafts at reasonable stages; casting lists and offer terms for roles subject to approval; and reasonable access to the set at mutually convenient times, subject to safety and production constraints.

9. Chain of Title; Representations; Indemnities

• Author Reps and Warranties: Sole owner of all rights necessary to grant the option and rights herein; no conflicting grants; work is original (excluding properly licensed excerpts, if any); no infringement, defamation, invasion of privacy/publicity, or other legal violations to Author’s knowledge; no pending claims. Author will obtain and provide any publisher waivers or reversion instruments required.
• Producer Reps: Producer is duly organized and has authority to enter this agreement; will secure all third-party rights it introduces (screenwriter, director, talent, music, artwork).
• Indemnities: Mutual indemnities for breach of respective reps, warranties, and covenants; Producer to maintain E&O insurance customary for feature films, naming Author as an additional insured.

10. Moral Rights; Integrity; Credit Preservation

• The parties acknowledge that in some jurisdictions moral rights are inalienable (e.g., author’s rights of attribution and integrity recognized under the Berne Convention art. 6bis and, where applicable, under local copyright statutes such as the PRC Copyright Law recognizing rights of authorship and integrity). Nothing herein shall be construed to waive non-waivable rights. Producer will not distort or mutilate the Property in a manner prejudicial to Author’s honor or reputation, and will comply with the approval and credit provisions as a material condition.

11. Reserved/Ancillary Rights and Derivatives

• Sequels/Remakes/Prequels/Spin-offs based on the Picture: Producer shall have exclusive rights to audiovisual derivatives of the Picture (including remakes and sequels) provided they derive from Producer’s film; Author retains literary sequel/prequel rights in print. Producer shall have a first negotiation/last refusal right for audiovisual adaptations of Author’s literary sequels/prequels.
• Television/Series Rights: [Include or exclude]. If excluded, Producer shall have right of first negotiation/last refusal for a limited period.

12. Turnaround; Reversion

• If Producer fails to commence principal photography within [X] months after option exercise, and no force majeure applies, all motion picture rights revert to Author, subject to Producer’s continued rights in any original screenplays created by Producer personnel (not including rights in the Property) and subject to repayment of unrecouped development costs only if Producer elects to retain screenplay rights; no reversion impairs Author’s right to re-sell the Property free of claims to the underlying rights.

13. Assignment; Financing; Lender Protections

• Producer may assign to an affiliated production entity and to financiers/distributors as customary, provided Author’s approval and credit rights survive and are binding on successors and assigns. Author agrees to execute customary lender/financier notices of assignment and to recognize standard step-in rights that do not diminish Author’s approval and credit protections.

14. Accounting; Audit

• Producer shall render semi-annual statements for any contingent compensation with payments within [30] days thereafter. Author has audit rights on reasonable notice not more than once per year, with underpayment thresholds for cost reimbursement.

15. Guild and Labor Compliance

• Producer shall comply with applicable guild, union, and employment laws in the relevant jurisdictions. Nothing herein requires Producer to violate guild rules; however, such compliance shall not excuse failure to obtain Author approvals required herein.

16. Confidentiality; Publicity

• Mutual confidentiality as to deal terms and development materials; no announcements without mutual approval, except as required by law or financing/distribution contracts.

17. Remedies; Limitation of Liability

• Without limiting injunctive relief for violations of Sections 5 (Credit) and 6 (Approvals) prior to release, the parties agree that post-release relief is limited to prospective corrective measures and damages. No special or consequential damages except as to third-party claims covered by indemnities.

18. Governing Law; Dispute Resolution

• Governing Law: [To be specified—e.g., New York law or the law of the principal production jurisdiction]. The agreement will be construed consistent with applicable copyright statutes (e.g., 17 U.S.C. §§ 101 et seq. for U.S. exploitation) and non-waivable moral rights provisions where applicable.
• Venue/Arbitration: Any dispute shall be submitted to binding arbitration before [forum, e.g., JAMS/CIETAC] in [city], with provisional relief available from a court of competent jurisdiction to enforce credit and approval rights.

19. Conditions Precedent; Deliverables

• Delivery by Author: Copy of the work as published (and any manuscript materials), publisher consents or reversion documents if required, copyright registration details (if registered), and a chain-of-title schedule.
• Condition Precedent: If a publisher controls any portion of adaptation or tie-in rights, execution of a publisher’s quitclaim or consent satisfactory to Producer.

20. Notices; Execution

• Notices in writing by email with courier hard copy; deemed received upon confirmation of delivery. The agreement may be executed in counterparts and electronically.

Notes on Legal Compliance and Industry Standards

• A signed writing is required to effectuate any transfer of copyright in the United States (17 U.S.C. § 204(a)). Recordation of the assignment with the U.S. Copyright Office is recommended for priority.
• Credit provisions are enforceable; injunctive relief is often available pre-release. Moral rights of attribution and integrity may be non-waivable under certain national laws, and the agreement above is drafted to respect those non-waivable rights while accommodating customary film production practices.

This term sheet is intended as a binding summary of principal deal points only if expressly stated by the parties; otherwise, it is a non-binding outline pending negotiation and execution of a long-form agreement.